Midkine Symposium April 2016: Midkine in the treatment of Myocardial infarction




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Midkine Symposium April 2016: Midkine in the treatment of Myocardial infarction
Released on: June 27, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Professor Peter Ferdinandy, CEO, Pharmahungary Group and Professor of Pharmacology and Clinical Pharmacology (Semmelweis University, Budapest, Hungary), describes the role of midkine in treating post-ischemic injury in myocardial infarction.
  • Summary
  • Transcript
  • Participants
  • Company
Professor Peter Ferdinandy, CEO, Pharmahungary Group and Professor of Pharmacology and Clinical Pharmacology (Semmelweis University, Budapest, Hungary), describes the role of midkine in treating post-ischemic injury in myocardial infarction.
Professor Peter Ferdinandy, CEO, Pharmahungary Group and Professor of Pharmacology and Clinical Pharmacology (Semmelweis University, Budapest, Hungary), describes the role of midkine in treating post-ischemic injury in myocardial infarction.
Prof. Peter Ferdinandy
Pharmahungary Group and Professor of Pharmacology and Clinical Pharmacology, Semmelweis University, Budapest, Hungary